Stability of Coagulation Factors in Thawed and Refreezing Previously Thawed Fresh Frozen Plasma after Various Times of Storage

Authors

  • Arporn Hongyantarachai Department of Clinical Pathology, Queen Sirikit National Institute of Child Health
  • Rujada Wanotayan Department of Clinical Pathology, Queen Sirikit National Institute of Child Health
  • Vandee Ningsanond Department of Clinical Pathology, Queen Sirikit National Institute of Child Health

Keywords:

Fresh frozen plasma, Refrozen fresh frozen plasma, Coagulation factors

Abstract

Abstract : Fresh Frozen Plasma (FFP) is widely used in patients with coagulation disorders. The problem is that the FFP request may be canceled after thawing of FFP. The aim of this study was to evaluate the possibility of reusing of the previously thawed FFP. Ten units of thawed FFP were studied for Kactivity of factor II, V, VIL VII X X X as frst thawed FFP thawed 2 hour refrozen FFP and thawed 4 hour refrozen FFP at 0, 2, 4, 6, 24 hours after thawing. The result of mean Mactivity of factor VII in frst thawed FFP only at 24 hours was statistically decreased compared with 0 hour but was still within the normal range. The results of mean %activity of factor Vill in thawed 2 and 4 hour refrozen FFP at 0 hour were statically decreased compared with 0 hour after first thawed but also were still within the normal range. There were statistically decreased in mean %activity of factor Vand VIII in thawed 2 and 4 hour refrozen FFP at 2 up to 24 hours compared with 0 hour after first thawed and factor V were less than the normal range Therefore first thawed FFP which stored at 4 C may be used up to 24 hours while thawed 2 and 4 hour refroen FFP which stored at 4'C may be used immediately after thawing.

Downloads

Download data is not yet available.

References

Consensus Conference. Fresh-frozen plasma. Indications and risks. JAMA 1985;253:551-3.

Snyder AJ, Gottschall JL, Menitove JE. Why is fresh frozen plasma transfused? Transfusion 1986;26:107-12.

Braunstein AH, Oberman HA. Transfusion of plasma components. Transfusion 1984;24:281-6.

Miller WV, Editor-in-chief. Technical manual. 7th edition 1977. American Association of Blood Banks, Washington DC P:42-3.

Farrugia A, Prowse C. Studies on the procurement of blood coagulation factor VIII: effects of plasma freezing rate and storage conditions on cryoprecipitate quality. J Clin Patho 1985;38:433-7.

Allain JP, Friedli H, Morgenthaler JJ, et al. What are the critical factors in the production and quality control of frozen plasma intended for direct transfusion or for fractionation to provide medically needed labile coagulation factors? Vox Sang 1983;44:246-59.

Blood component therapy : A physician's hand book 3th edition 1977. American Association of Blood Banks,

Washington DC P:20.

Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine 9th edition 1993. Oxford: Blackwell Scientific Publication. P:659.

Dzix WH, Riibner MA,Linehan SK. Refreezing previously thawed fresh-frozen plasma. Stability of coagulation factors V and VIII:C. Transfusion 1989:600-4.

Johnston M, Zipuisky A. Microtechnology for the study of the blood coagulation system in newborn infants. Canadian Journal of Medical Technology 1980;42:159-64.

Miller WV, Editor-in-chief. Technical Manual 7th edition 1977. American Association of Blood Banks, Washington DC P:360.

Nathan DG, Oski FA. Hematology of infancy and childhood 2nd edition 1981. W B. Saunders Company. P:1199

Downloads

Published

2018-12-30

Issue

Section

นิพนธ์ต้นฉบับ (Original article)